Biomerica (BMRA) Director Gary M. Huff Buys 31,250 Shares

What Happened
Gary M. Huff, a director of Biomerica, acquired 31,250 shares of the company's common stock in a private placement at $1.60 per share, for a total cost of $50,000. The purchase is reported as a coded transaction "P" (purchase), indicating an insider buy rather than a sale.

Key Details

• Transaction date(s): Securities Purchase Agreement dated August 20, 2026; acquisition reported as August 26, 2026.
• Filing date: Form 4 filed August 27, 2026 (report period 2026-08-26) — appears to be filed promptly.
• Price and amount: 31,250 shares at $1.60 per share; total = $50,000.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Notable footnote: The shares were purchased in a private placement pursuant to a Securities Purchase Agreement dated August 20, 2026, which included institutional investors (e.g., B. Riley Principal Capital, LLC) and certain board members and executive officers.

Context
This was a private placement purchase (not an open-market buy or option exercise), meaning the shares were acquired directly from the company under the SPA. Insider purchases can be interpreted by investors as an increase in the insider’s stake, but the filing itself provides no explanation of intent.